PepGen (PEPG) Share-based Compensation (2021 - 2026)

PepGen (PEPG) reported Share-based Compensation of $2.9 million for Q1 2026, down 16.81% on a YoY basis from $3.4 million in Q1 2025, and up 17.15% sequentially from $2.4 million in Q4 2025.

PepGen (PEPG) Share-based Compensation (2021 - 2026) Analysis & Trends

PepGen (PEPG) has 6 years of Share-based Compensation data on file, last reported at $2.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation fell 16.81% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $11.1 million (down 13.73% YoY), and the FY2025 full-year result was $15.8 million, down 46.8% from the prior year.
  • Share-based Compensation improved to $2.9 million in Q1 2026, from $2.4 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $25.6 million in Q2 2025 to a low of $815000.0 in Q1 2022.
  • A 5-year average of $4.8 million and a median of $2.4 million in 2025 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation jumped 3359.64% in 2022 and slumped 91.7% in 2023, its largest moves.
  • Tracing PEPG's Share-based Compensation over 5 years: stood at $23.1 million in 2022, then tumbled by 91.7% to $1.9 million in 2023, then soared by 74.14% to $3.3 million in 2024, then slipped by 27.19% to $2.4 million in 2025, then climbed by 17.15% to $2.9 million in 2026.
  • Business Quant data shows PEPG's Share-based Compensation at $2.9 million in Q1 2026, $2.4 million in Q4 2025, and $2.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 PepGen 145.09 Mn 145.09 Mn - 2.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.86 Mn
Mar 31, 2026 2.86 Mn
Dec 31, 2025 2.44 Mn
Dec 31, 2025 2.44 Mn
Sep 30, 2025 2.38 Mn
Sep 30, 2025 2.38 Mn
Jun 30, 2025 25.60 Mn
Jun 30, 2025 25.60 Mn
Mar 31, 2025 3.43 Mn
Mar 31, 2025 3.43 Mn
Dec 31, 2024 3.35 Mn
Dec 31, 2024 3.35 Mn
Sep 30, 2024 3.23 Mn
Sep 30, 2024 3.23 Mn
Jun 30, 2024 2.86 Mn
Jun 30, 2024 2.86 Mn
Mar 31, 2024 2.02 Mn
Mar 31, 2024 2.02 Mn
Dec 31, 2023 1.92 Mn
Dec 31, 2023 1.92 Mn